Answers are grounded in this paper and cite their sources.
Review highlights elevated oxidative stress and impaired antioxidant defenses in multiple sclerosis, suggesting biomolecules could serve as early prognostic markers.
• Oxidative stress drives lesion development in multiple sclerosis. • MS patients show high OS and reduced antioxidant defense early on. • OS markers may help in early prognosis and guide timely treatment. • OS can both trigger and worsen MS, creating a harmful cycle. • More research is needed to link OS with neuroinflammation in MS.
No takes yet. Share an insight, caveat, or question.
Bellisario et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: